Researcher
Christine Desmedt
- Disciplines:Oncology
Affiliations
- Department of Oncology (Department)
Member
From1 Oct 2018 → 25 Dec 2018 - Laboratory for Translational Breast Cancer Research (Division)
Member
From1 Oct 2018 → Today - Laboratory for Translational Breast Cancer Research (Division)
Responsible
From1 Oct 2018 → Today
Projects
1 - 10 of 18 results
- Characterization of the tumor microenvironment of breast cancer metastasesFrom11 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- LIQUIDEVO: Unravelling breast cancer heterogeneity, progression and treatment resistance in the context of a rapid post-mortem institutional tissue donation program using phylogenetic reconstruction algorithms and an Open Science approach.From1 Oct 2021 → TodayFunding: FWO senior postdoctoral fellowship
- LIQUIDEVO: Unravelling breast cancer heterogeneity, progression and treatment resistance in the context of a rapid post-mortem institutional tissue donation program using phylogenetic reconstruction algorithms and an Open Science approach..From1 Oct 2021 → TodayFunding: BOF - postdoctoral mandates
- UPTIDER (UZ/KU Leuven Program for post-mortem Tissue Donation to Enhance Research), a unique setting to unravel treatment resistance and disease progression in patients with breast cancer.From1 Oct 2021 → TodayFunding: BOF - projects
- Clinical, experimental and molecular characterization of liver metastases from breast cancer patients.From1 Mar 2021 → TodayFunding: Foundations, funds and other with scientific goal
- Facing Adiposity in personalizing Treatment of Breast Cancer PatientsFrom1 Mar 2021 → TodayFunding: H2020 - Frontier Research (ERC)
- FAT-IBC: Facing adiposity in personalizing treatment of Inflammatory Breast Cancer patients.From1 Jan 2021 → TodayFunding: FWO research project
- Unraveling the association between adiposity and breast cancer biology by in silico analysis of bulk and single-cell omics dataFrom31 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- FAT-ILC: Facing Adiposity in personalizing treatment of Invasive Lobular breast Cancer patients.From12 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Facing increased adiposity in treating metastatic breast cancerFrom1 Oct 2019 → 30 Sep 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 60 results
- Is cancer biology different in older patients?(2021)
Authors: Yannick Van Herck, Annelies Feyaerts, Shabbir Alibhai, Demetris Papamichael, Lore Decoster, Yentl Lambrechts, Michael Pinchuk, Oliver Bechter, Jaime Herrera-Caceres, Frédéric Bibeau, et al.
Pages: E663 - E677 - Comparison of the tumor immune microenvironment of primary hormone receptor-negative HER2-positive and triple negative breast cancer(2021)
Authors: Hanne Vos, Kathleen Lambein, François Richard, Bram Marien, Ines Nevelsteen, Kevin Punie, Hans Wildiers, Lieze Berben, Annouschka Laenen, Giuseppe Floris, et al.
Number of pages: 5 - How Researchers, Clinicians and Patient Advocates Can Accelerate Lobular Breast Cancer Research(2021)
Authors: Leigh Pate, Christine Desmedt, Otto Metzger, Laurie Burgess Hutcheson, Claire Turner, Siobhan Freeney, Steffi Oesterreich
Number of pages: 12 - Downregulation of the m6A RNA demethylase FTO in epithelial cancers promotes EMT-mediated tumor progression and confers sensitivity to Wnt inhibitors(2021)
Authors: Jana Jeschke, Evelyne Collignon, Clemance Al Wardi, Mohammad Krayem, Martin Bizet, Yan Jia, Soizic Garaud, Zena Wimana, Emilie Calonne, Bouchra Hassabi, et al.
Pages: 611 - 628 - Assessment of mammary adiposity in breast cancer using digital pathology(2021)
Authors: Edoardo Isnaldi, Christine Desmedt, Gabriele Zoppoli
- A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer(2021)
Authors: Ayse Bassez, Hanne Vos, Laurien Van Dyck, Giuseppe Floris, Ingrid Arijs, Christine Desmedt, Bram Boeckx, Marlies Vanden Bempt, Ines Nevelsteen, Kathleen Lambein, et al.
Pages: 820 - +Number of pages: 40 - The genomic landscape of carcinomas with mucinous differentiation(2021)
Authors: Bastien Nguyen, Francisco Sanchez-Vega, Christopher J Fong, Walid K Chatila, Amir Momeni Boroujeni, Fresia Pareja, Britta Weigelt, Christos Sotiriou, Denis Larsimont, Jorge S Reis-Filho, et al.
Number of pages: 7 - Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy(2021)
Authors: Maria Alice Franzoi, Daniel Eiger, Lieveke Ameye, Noam Ponde, Rafael Caparica, Claudia De Angelis, Mariana Brandao, Christine Desmedt, Serena Di Cosimo, Nuria Kotecki, et al.
Pages: 462 - 470Number of pages: 9 - Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ(2021)
Authors: Mathilde MM Almekinders, Michael Schaapveld, Bram Thijssen, Lindy L Visser, Tycho Bismeijer, Joyce Sanders, Edoardo Isnaldi, Ingrid Hofland, Marjolijn Mertz, Lodewyk FA Wessels, et al.
Number of pages: 10 - Body Mass Index and Weight Change in Patients With HER2-Positive Early Breast Cancer: Exploratory Analysis of the ALTTO BIG 2-06 Trial(2021)
Authors: Samuel Martel, Matteo Lambertini, Dominique Agbor-Tarh, Noam F Ponde, Andrea Gombos, Vicki Paterson, Florentine Hilbers, Larissa Korde, Anna Manukyants, Amylou Dueck, et al.
Pages: 181 - +Number of pages: 22